MARKET

SER

SER

Serina Therapeutics
AMEX
5.34
-0.33
-5.82%
After Hours: 5.34 0 0.00% 16:05 04/01 EDT
OPEN
5.75
PREV CLOSE
5.67
HIGH
5.75
LOW
5.00
VOLUME
15.29K
TURNOVER
--
52 WEEK HIGH
14.57
52 WEEK LOW
3.810
MARKET CAP
53.04M
P/E (TTM)
-3.5273
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SER last week (0324-0328)?
Weekly Report · 1d ago
JonesTrading Reaffirms Their Buy Rating on Serina Therapeutics (SER)
TipRanks · 03/25 20:05
Form 10-K: Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the Fiscal Year Ended December 31, 2024
Press release · 03/24 20:34
Serina Therapeutics GAAP EPS of -$1.51, revenue of $0.06M misses by $0.01M
Seeking Alpha · 03/24 20:34
Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
Barchart · 03/24 15:30
Serina Therapeutics Unveils Breakthrough in POZ-Lipid Technology
TipRanks · 03/24 10:57
Weekly Report: what happened at SER last week (0317-0321)?
Weekly Report · 03/24 10:48
Serina Therapeutics to present on POZ-lipid technology at ACS Spring 2025
TipRanks · 03/24 10:36
More
About SER
More
Serina Therapeutics Inc. is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. The Company's POZ Platform provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Its proprietary POZ technology is based on a synthetic, water soluble, low viscosity polymer called poly(2-oxazoline). Its POZ technology is engineered to provide greater control in drug loading and more precision in the rate of release of attached drugs delivered via subcutaneous injection. SER-252 is the Company’s lead candidate for advanced Parkinson’s disease. SER-252 is an investigational apomorphine therapy developed with its POZ platform and designed to provide continuous dopaminergic stimulation.
Recently
Symbol
Price
%Change

Webull offers Serina Therapeutics Inc stock information, including AMEX: SER real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SER stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SER stock methods without spending real money on the virtual paper trading platform.